Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer’s disease
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Cognitive decline is a cardinal feature of Alzheimer's disease (AD) predominantly linked to synaptic failure, disrupted network connectivity and neurodegeneration. A large body of evidence associates the Wnt pathway with synaptic modulation and cognitive processes, suggesting a potential role for aberrant Wnt signaling in cognitive impairment. In fact, altered expression of key Wnt pathway components has been found in brains of AD patients as well as AD animal models supporting a deregulated pathway in AD. The evidence for deregulated Wnt signaling in AD, however, remains sparse and focused on isolated Wnt pathway components. Here, we provide the first comprehensive pathway-focused evaluation of the Wnt pathway in the entorhinal cortex and hippocampus of AD brains. Our data demonstrate altered Wnt pathway gene expression at all levels of the pathway in both medial temporal lobe regions with the hippocampus exhibiting most pronounced changes. Furthermore, the Wnt pathway constituents Wnt7b and Tcf7l1/Tcf3 showed overlapping gene expression alterations across both medial temporal lobe structures, while β-catenin was inversely expressed between brain regions. We also identified total protein alterations of the intracellular Wnt pathway signaling components β-catenin, Gsk3β and Tcf7l1/Tcf3 and the phosphorylation state of β-catenin and Gsk3β in the hippocampus suggestive of a link between AD and aberrant canonical activity. Alterations in Gsk3β co-appeared with hippocampal kinase-targeted hyperphosphorylation at specific tau epitope in soluble pretangles and prominent tau aggregation exclusively in insoluble neurofibrillary tangles of AD subjects. The Wnt pathway-focused approach confirms altered Wnt signaling in the neurodegenerative AD brain and highlights the potential role of the pathway as a therapeutic target for the treatment of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Shh pathway displays upregulation of its components, Shh, SMO, GLI1, and GLI2, in the hippocampus of human and mouse AD models, whereas PTCH, GLI3, and Wnt signaling components are downregulated [111,112].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [112]
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Pfaffl, M. W., Tichopad, A., Prgomet, C., & Neuvians, T. P. (2004) · Biotechnology Letters · doi:10.1023/b:bile.0000019559.84305.47 · Cited by 5,065
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · cited 1×
“Functional imaging studies have furthermore demonstrated a breakdown in the connectivity between MTL structures and the rest of the brain in AD highlighting the hippocampus and entorhinal cortex in cognitive impairment (Allen et al. 2007; Greicius et al. 2004).”
BackgroundThe Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Cited by
Lim, R. G., Quan, C., Reyes-Ortiz, A. M., Lutz, S. E., Kedaigle, A. J., Gipson, T. A., Wu, J., Vatine, G. D., Stocksdale, J., Casale, M. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.021 · Cited by 253
Role of Wnt Signaling in Adult Hippocampal Neurogenesis in Health and Disease
Arredondo, S. B., Valenzuela-Bezanilla, D., Mardones, M. D., & Varela‐Nallar, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00860 · Cited by 174
Smith, A. R., Smith, R. G., Pishva, E., Hannon, E., Roubroeks, J. A. Y., Burrage, J., Troakes, C., Al-Sarraj, S., Sloan, C., Mill, J., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0636-y · Cited by 118
Impaired Wnt Signaling in the Prefrontal Cortex of Alzheimer’s Disease
Folke, J., Pakkenberg, B., & Brudek, T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1103-z · Cited by 123
Self-citationHow Wnt Signaling Builds the Brain: Bridging Development and Disease
Noelanders, R., & Vleminckx, K. (2017) · The Neuroscientist · doi:10.1177/1073858416667270 · Cited by 107
Primary cilia and ciliary signaling pathways in aging and age-related brain disorders
Ma, R., Kutchy, N. A., Chen, L., Meigs, D. D., & Hu, G. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105607 · Cited by 114
Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases
Rydbirk, R., Folke, J., Winge, K., Aznar, S., Pakkenberg, B., & Brudek, T. (2016) · Scientific Reports · doi:10.1038/srep37116 · Cited by 114
Self-citationWnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials
Neiheisel, A., Kaur, M., Ma, N., Havard, P., & Shenoy, A. K. (2021) · International Journal of Cancer · doi:10.1002/ijc.33811 · Cited by 108
The role of PI3K signaling pathway in Alzheimer’s disease
Pan, J., Yao, Q., Wang, Y., Chang, S., Li, C., Wu, Y., Shen, J., & Yang, R. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1459025 · Cited by 89
Role of Hydrazine-Related Chemicals in Cancer and Neurodegenerative Disease
Spencer, P. S., & Kisby, G. E. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00150 · Cited by 81
Lanke, V., Moolamalla, S. T. R., Roy, D., & Vinod, P. K. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00153 · Cited by 76
Rydbirk, R., Elfving, B., Andersen, M. D., Langbøl, M. A., Folke, J., Winge, K., Pakkenberg, B., Brudek, T., & Aznar, S. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.014 · Cited by 74
Self-citationGarcía‐Velázquez, L., & Arias, C. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.06.001 · Cited by 73
Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging
Chen, D., Xie, R., Shu, B., LANDAY, A. L., Wei, C., Reiser, J., Spagnoli, A., Torquati, A., Forsyth, C. B., Keshavarzian, A., et al. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13945 · Cited by 71
Verheyen, A., Diels, A., Reumers, J., Van Hoorde, K., Van den Wyngaert, I., van Outryve d’Ydewalle, C., De Bondt, A., Kuijlaars, J., De Muynck, L., De Hoogt, R., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.06.022 · Cited by 69
Dengler-Crish, C. M., Ball, H. C., Lin, L., Novak, K. M., & Cooper, L. N. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.021 · Cited by 58
Surya, K., Manickam, N., Jayachandran, K. S., Kandasamy, M., & Anusuyadevi, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220559 · Cited by 49
VARAdb: a comprehensive variation annotation database for human
Pan, Q., Liu, Y.-J., Bai, X., Han, X., Jiang, Y., Ai, B., Shi, S.-S., Wang, F., Xu, M., Wang, Y., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa922 · Cited by 47
Martorell, P., Llopis, S., González, N., Ramón, D., Serrano, G., Torrens, A., Serrano, J. M., Navarro, M., & Genovés, S. (2016) · Food Science & Nutrition · doi:10.1002/fsn3.388 · Cited by 46
Liu, X., Wang, K., Wei, X., Xie, T., Lv, B., Zhou, Q., & Wang, X. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03227-y · Cited by 41
Ellison, E. M., Bradley-Whitman, M. A., & Lovell, M. A. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0969-y · Cited by 35
Identification of Immune Cells and Key Genes associated with Alzheimer's Disease
Liu, C., Zhang, X., Chai, H., Xu, S., Liu, Q., Luo, Y., & Li, S. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.66422 · Cited by 36
Hypoxia-inducible factor-2α is crucial for proper brain development
Kleszka, K., Leu, T., Quinting, T., Jastrow, H., Pechlivanis, S., Fandrey, J., & Schreiber, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-75838-4 · Cited by 35
Yan, H., Feng, L., & Li, M. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s380612 · Cited by 35
Zhang, L., Sun, C., Jin, Y., Gao, K., Shi, X., Qiu, W., Ma, C., & Zhang, L. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161254 · Cited by 34
Martin, B., Wang, R., Cong, W., Daimon, C. M., Wu, W. W., Ni, B., Becker, K. G., Lehrmann, E., Wood, W. H., Zhang, Y., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773820 · Cited by 32
Conserved gene signatures shared among MAPT mutations reveal defects in calcium signaling
Minaya, M., Mahali, S. K., Iyer, A. K., Eteleeb, A. M., Martinez, R. J., Huang, G., Budde, J., Temple, S., Nana, A. L., Seeley, W. W., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1051494 · Cited by 30
WNT Signaling Is a Key Player in Alzheimer’s Disease
Inestrosa, N. C., Tapia‐Rojas, C., Cerpa, W. F., Cisternas, P., & Zolezzi, J. M. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_532 · Cited by 29
Macyczko, J. R., Wang, N., Zhao, J., Ren, Y., Lü, W., Ikezu, T. C., Zhao, N., Liu, C., Bu, G., & Li, Y. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03065-1 · Cited by 28
The transcriptional landscape of Alzheimer’s disease and its association with Wnt signaling pathway
Martínez, M., & Inestrosa, N. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.029 · Cited by 26
Therapies for Alzheimer’s disease: a metabolic perspective
Domingues, R., Pereira, C., Cruz, M. T., & Silva, A. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.01.011 · Cited by 25
Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation
Zhou, L., Chen, D., Huang, X., Long, F., Cai, H., Yao, W., Chen, Z., Liao, Z.-J., Deng, Z., Tan, S., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00281 · Cited by 23
Wang, D., Li, B., Wu, Y., & Li, B. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00695-3 · Cited by 23
Ding, Y., Li, L., Wang, S., Cao, Y., Yang, M., Dai, Y., Lin, H., Li, J., Liu, Y., Wang, Z., et al. (2023) · Biological Research · doi:10.1186/s40659-023-00472-z · Cited by 21
Hypermethylation of Mest promoter causes aberrant Wnt signaling in patients with Alzheimer’s disease
Prasad, R., Jung, H., Tan, A., Song, Y., Moon, S., Shaker, M. R., Sun, W., Lee, J.-H., Ryu, H., Lim, H. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99562-9 · Cited by 19
Pei, X., Hu, F., Luo, F., Huang, X., Li, X., Xing, S., & Long, D. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4213 · Cited by 19
Frizzled 1 and Wnt1 as new potential therapeutic targets in the traumatically injured spinal cord
González, P., González‐Fernández, C., Campos‐Martín, Y., Mollejo, M., Carballosa-Gautam, M. M., Marcillo, A. E., Norenberg, M. D., & Rodríguez, F. J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03427-4 · Cited by 19
Aberrant DNA methylation associated with Alzheimer's disease in the superior temporal gyrus
Gao, Z., Fu, H., Zhao, L., Sun, Z., Yang, Y., & Zhu, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5394 · Cited by 18
Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer’s disease therapy
Romero, A., Ramos, E., & Marco, J. L. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262679 · Cited by 16
Hu, H., Mei, J., Cai, Y., Ding, H., Niu, S., Zhang, W., & Fang, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1090223 · Cited by 13
Renovascular hypertension associated with neurofibromatosis: two cases and review of the literature.
Nakhoul, F. M., Green, J., Angel, A., Ofer, A., Ben‐Izhak, O., & Lewin, M. (2001) · PubMed · Cited by 12
Tao, C., Nichols, T. E., Hua, X., Ching, C. R. K., Rolls, E. T., Thompson, P. M., & Feng, J. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.08.027 · Cited by 11
Hou, J., Hess, J., Zhang, C., van Rooij, J., Hearn, G. C., Fan, C. C., Faraone, S. V., Fennema‐Notestine, C., Lin, S., Escott‐Price, V., et al. (2024) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.33019 · Cited by 9
Ghasemi, A., Qaffaripour, Z., Tourani, M., Saleki, K., Rahmani-Kukia, N., Khatami, S. H., & Taheri‐Anganeh, M. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114434 · Cited by 9
Ghisays, V., Nguyen, E. T., Streicher, J., Pease, N. A., Fitzgerald, M. E., Estrada, C. M., Franco, A. C. G., Vinnedge, L. M. P., & Solomon, M. B. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.11.025 · Cited by 9
A suggested shared aetiology of dementia - a colocalization study
Yu, X., Lophatananon, A., Mekli, K., Burns, A. S., Muir, K. R., & Guo, H. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.05.005 · Cited by 7
Cross study transcriptomic investigation of Alzheimer’s brain tissue discoveries and limitations
Tsurukawa, F. K., Mao, Y., Sanchez-Villalobos, C., Khanna, N., Crasto, C. J., Lawrence, J. J., & Pal, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-01017-y · Cited by 6
Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production
Poksay, K. S., Sheffler, D. J., Spilman, P. R., Campagna, J. J., Jagodzinska, B. M., Descamps, O., Gorostiza, O. F., Matalis, A., Mullenix, M. C., Bredesen, D. E., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00046 · Cited by 6
The association of the Wnt/β-catenin signaling pathway with Alzheimer's disease
Ma, J., Liu, Y., Lu, D., & Sun, Q. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110754 · Cited by 5
Association of DISC1 Polymorphisms with Late-Onset Alzheimer’s Disease in Northern Han Chinese
Zhang, X., Wang, H.-F., Tan, M., Wan, Y., Kong, L., Zheng, Z.-J., Tan, C., Zhang, W., Wang, Z., Tan, L., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9881-7 · Cited by 5
Modulatory effect of zeolite in an experimental rat model of Alzheimer's disease
Omran, A., Mohamed, E. A., Elraouf, O. A., Georgy, G. S., & Balah, A. (2022) · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences · doi:10.21608/aijpms.2022.107355.1097 · Cited by 5
Bando, S. Y., Bertonha, F. B., Menezes, P. H. N., Takahara, A. K., Khaled, N. A., Santos, P., Junqueira, M. D. S., Junior, R. M. C., & Moreira‐Filho, C. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-37535-w · Cited by 3
Verheyen, A., Diels, A., Reumers, J., Hoorde, K. V., den Wyngaert, I. V., d’Ydewalle, C. V. O., Bondt, A. D., Kuijlaars, J., Muynck, L. D., Hoogt, R. D., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.07.007 · Cited by 3
Safety and Nanotoxicity Aspects of Nanomedicines for Brain-Targeted Drug Delivery
Catalán-Figueroa, J., & Morales, J. O. (2020) · Neuromethods · doi:10.1007/978-1-0716-0838-8_10 · Cited by 3
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
“The Shh pathway displays upregulation of its components, Shh, SMO, GLI1, and GLI2, in the hippocampus of human and mouse AD models, whereas PTCH, GLI3, and Wnt signaling components are downregulated [111,112].”
Mahon, K., Abo-Ismail, M. K., Auten, E., Manjarín, R., & Maj, M. A. (2025) · Biomedicines · doi:10.3390/biomedicines13071567 · Cited by 1
The Association Between Serum Copper Levels and Proteomics in Mild Cognitive Impairment
Rattanakarun, R., Shantavasinkul, P. C., Witoonpanich, P., Roytrakul, S., & Sirivarasai, J. (2026) · Nutrients · doi:10.3390/nu18081171 · Cited by 1
Xu, Q., Wang, L., Song, Q., Chen, S., Du, K., Teng, X., & Zou, C. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08811-3 · Cited by 1
Tejeda, M., Farrell, J. J., Zhu, C., Wetzler, L. M., Lunetta, K. L., Bush, W. S., Martin, E. R., Wang, L., Schellenberg, G. D., Pericak‐Vance, M. A., et al. (2026) · medRxiv · doi:10.64898/2026.04.16.26351043 · Cited by 1
Epigenetic Modifications to Cytosine and Alzheimer’s Disease
Ellison, E. M. (2017) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2017.398
Exploring the Role of the DEK Oncogene as a Novel Player in Learning and Memory
Ghisays, V. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
Liu, H.-C., Peng, Y.-S., & Lee, H.-C. (2019) · PeerJ · doi:10.7717/peerj.7309
Prasad, R., Jung, H., Tan, A., Song, Y., Moon, S., Shaker, M. R., Sun, W., Lee, J.-H., Ryu, H., Lim, H. K., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-474622/v1
The role of the Blood-Brain Barrier in cellular communication: A review
Fernando, A., Shahib, A. K., Raghu, R., & Ganapathy, M. (2023) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2023.13.1.0027
Singh, K., Ahmad, I., Jain, D., Mim, T. J., Noman, A. A., Shihab, M. P. R., Kondaveeti, S. B., Gupta, J. K., & Wal, P. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70880
Bitar, F. E., Dawsari, G. A., Qadi, N., Rajeh, S. A., Abouelhoda, M., Alsubaie, S., Majrashi, N., Magrashi, A. I., Amari, H. A. A., Alghamdi, F., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1765569
Wnt/β-catenin signaling dysregulation in Alzheimer’s disease and therapeutic opportunities
Alkhalifa, A. E., Al-Ghraiybah, N. F., Al-Gharaibeh, A. F., & Kaddoumi, A. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.120020
Hu, H., Mei, J., Cai, Y., Ding, H., Niu, S., Zhang, W., & Fang, X. (2023) · doi:10.3389/fnagi.2023.1090223.s002
Metadata
- Authors
- Riise, J., Plath, N., Pakkenberg, B., & Parachikova, A.
- Affiliations
- University of Copenhagen (DK)
- Lundbeck (Denmark) (DK)
- Bispebjerg Hospital (DK)
- Corresponding author
- Riise, Jesper
- Venue
- Journal of Neural Transmission
- Published
- 2015-02-14
- Volume
- 122
- Issue
- 9
- Pages
- 1303-1318
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2022717467
- Cited by
- 66
- References
- 71
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 11 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 11 · 2016: 5
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, Wnt signaling, medial temporal lobe, hippocampus, entorhinal cortex, Wnt7b, β-catenin, GSK3β, β-catenin phosphorylation, tau hyperphosphorylation, tau aggregation, neurofibrillary tangles, cognitive impairment, synaptic dysfunction, gene expression changes
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Hippocampus, Humans, Male, Middle Aged, Phosphorylation, RNA, Messenger, Immunoblotting, tau Proteins, Entorhinal Cortex, Wnt Signaling Pathway, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.